Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

10

Revenue 2014

Takeda

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Takeda's 2013 sales performance.

Woodford investment pushes Dementia Discovery Fund to £100m

Woodford investment pushes Dementia Discovery Fund to £100m

therapies. The DDF's chief scientific officer - former Takeda drug discovery head Tetsu Maruyama - said that the fund's first year of investing "has shown clearly how our new way of

FDA fast-tracks Pfizer and Lilly's tanezumab

FDA fast-tracks Pfizer and Lilly's tanezumab One competitor - Amgen - has been developing its own candidate called fulranumab, but former partners Johnson &Johnson and Takeda handed back rights to the project last year.

Takeda and Marvel extend IBD cartoon initiative

Takeda and Marvel extend IBD cartoon initiative Takeda and Marvel extend IBD cartoon initiative. Next chapter of IBD Unmasked released to celebrate World IBD Day. ... Takeda Pharmaceuticals has launched the next part of its cartoon-based disease awareness partnership with Marvel.

Finalists 2017

by Aurora Healthcare Communications. for Takeda. Telling the story of the transformational power of AstraZeneca’s early science. ... for Takeda Pharmaceuticals International AG – Europe and Canada. Accelerating Change for Stroke Patients Through The

Novartis' Zykadia claims US approval for first-line lung cancer

Novartis' Zykadia claims US approval for first-line lung cancer Meanwhile additional competition in the ALK inhibitor market is looming following accelerated approval of Takeda's Alunbrig (brigatinib) by the FDA a few weeks ago.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Takeda
Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA
Japan revenue 2014
1: Takeda
2: Otsuka
3: Meiji
4: Astellas
5: Daiichi Sankyo
6: Teijin
7: Eisai
8: Chugai
9: Mitsubishi Tanabe
10: Kyowa Hakko Kirin
11: Taisho
12: Shionogi
13: Hisamitsu
14: Santen
15: Ono
16: Kyorin
17: Nichi-Iko
18: Mochida
19: Sawai
20: Kaken
21: Kissei
22: Zeria
23: Towa
24: Torii
25: Daito
Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte
Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda
Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company
Metabolic revenue 2014
1: Novo Nordisk
2: Sanofi
3: Merck & Co.
4: Lilly
5: AstraZeneca
6: Takeda
7: Novartis
8: Amgen
9: Bayer
10: Merck KGaA
11: Salix Pharmaceuticals
12: AbbVie
13: Dainippon Sumitomo Pharma
14: Kyowa Hakko Kirin
15: Mitsubishi Tanabe

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics